1. Introduction
===============

As one of the most uncommon malignant diseases, malignant neoplasms of the sinonasal tract account for approximately 0.3% of all cancers, and about 3% of head and neck carcinomas,^\[[@R1],[@R2]\]^ with an overall incidence rate of 0.5 to 1.0 cases per 100,000 population annually.^\[[@R3]\]^ The most common histological subtypes in the nasal sinuses are squamous cell carcinoma (SCC) and adenocarcinoma. Sinonasal squamous cell carcinoma (SNSCC) is the most common type and accounts for approximately 60% to 75% of sinonasal cancer cases.^\[[@R4],[@R5]\]^ Due to the relatively asymptomatic pattern of tumor growth, the majority of SNSCC patients are diagnosed at an advanced stage. Patients have a low average 5-year survival rate and poor outcomes.^\[[@R6],[@R7]\]^

Although the existence of many factors are correlated with SNSCC, such as cigarette smoking, wood dust, nickel, and leatherworking, these risk factors do not necessarily associate with a late stage of SNSCC.^\[[@R8]\]^ Recently, accumulating evidence suggests that a number of genetic alterations may contribute to the initiation and progression of SNSCC.^\[[@R9]--[@R12]\]^ The *p53* gene is a tumor suppressor gene mapped to chromosome 17p13, encodes the p53 protein, which involves in the regulation of the cell cycle, the inhibition of DNA synthesis, the function of DNA repair and apoptosis.^\[[@R13]--[@R15]\]^ The *p53* mutation is the most commonly found genetic alterations in various human carcinomas,^\[[@R16],[@R17]\]^ and the overexpression of p53 detected by immunohistochemistry (IHC) in most of cases (85%) is consistent with an underlying mutation.^\[[@R18]\]^ Thus, p53 expression may be considered as an indicator of *p53* gene mutation.

Due to the small sample size problem of individual studies with the low statistical power in SNSCC, therefore, we first performed a comprehensive meta-analysis of all published articles to determine the association between p53 expression and SNSCC by comparing cancer cases with benign sinonasal papillomas and normal sinonasal mucosa. In addition, we also evaluated the correlation of p53 expression with clinicopathological characteristics in SNSCC.

2. Materials and methods
========================

2.1. Search for eligible studies
--------------------------------

We identified eligible studies by searching a range of online electronic databases (PubMed, EMBASE, EBSCO, and Cochrane Library) prior July 27, 2016, without language or date-of-publication limitations. The keywords and search terms included the following: (sinonasal OR nasal OR paranasal sinuses) AND (cancer OR carcinoma OR tumor OR squamous cell OR SCC OR papilloma) AND (p53 OR p53 protein) AND (expression OR overexpression OR hyperexpression). In addition, we manually scanned the reference lists of the identified articles to identify the other potential studies.

2.2. Selection criteria
-----------------------

Eligible articles included in this meta-analysis must meet the following inclusion criteria: the patients were limited to SNSCC by histopathological confirmation; control groups were divided into benign sinonasal papillomas and normal sinonasal mucosa; case--control or cohort studies had to provide the sufficient information regarding the frequency of p53 expression to evaluate the correlation between p53 expression and SNSCC for this study; if more than one article using the same sample data were published, only most recent article or article with the largest sample size was included in the present study. Studies excluded did not meet the above selection criteria.

2.3. Ethical review from patients
---------------------------------

Although this meta-analysis was not primary research involving human specimens, this research was a secondary analysis with regard to human subject data published in the public domain.

2.4. Data extraction
--------------------

The following data were retrieved from eligible studies: the first author\'s surname, year of publication, country, ethnicity, control type, detection method, number of case and control samples, frequency of p53 expression in cases and controls, and clinicopathological parameters such tumor differentiation and histological type. Two reviewers (Fang Qi and Zhiqiang Gao) independently extracted relevant data from each study. To resolve disagreements between 2 reviewers, any disagreements about study selection and data extraction were discussed by all authors.

2.5. Statistical analysis
-------------------------

This meta-analysis was carried out using the STATA software (version 12.0, Stata Corporation, College Station, TX). The pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated and summarized to estimate the strength of association between p53 expression and SNSCC in case versus controls. Additionally, we also determined whether the expression of p53 protein was correlated with tumor differentiation and histological type in cancer. Between-study heterogeneity was examined using the Chi-square test and *Q* statistics.^\[[@R19]\]^ The pooled OR was calculated under the random-effects model. If substantial heterogeneity was found in this study (*P* \< 0.1), a sensitivity analysis was performed to estimate the influence of a single study on the pooled OR and the effect of deleting a single study on the stability of the results.^\[[@R20],[@R21]\]^ The potential publication bias was identified by Egger test.^\[[@R22]\]^*P*-value \<0.05 was considered to be statistically significant for the pooled ORs and 95% CIs with more than 1 or less than 1.

3. Results
==========

3.1. Characteristics of eligible studies
----------------------------------------

Figure [1](#F1){ref-type="fig"} shows the detailed procedure of included studies selection. Three hundred thirty-four studies were identified from an original literature search of electronic databases and a manual search. Ultimately, a total of 17 studies fulfilled the above select criteria and were included in the current meta-analysis.^\[[@R9],[@R23]--[@R38]\]^ Among the 17 articles published in English, the publication years ranged from 1998 to 2015. Sixteen studies including 229 SNSCC and 675 benign papilloma patients evaluated the relationship between p53 expression and SNSCC in cancer versus benign sinonasal papillomas.^\[[@R9],[@R23]--[@R30],[@R32]--[@R38]\]^ Five studies involving 112 SNSCC patients and 73 normal sinonasal mucosa estimated the relationship between p53 expression and SNSCC in cancer versus normal sinonasal mucosa.^\[[@R30],[@R34],[@R35],[@R37],[@R38]\]^ Three studies with 72 SNSCC patients evaluated the correlation between p53 expression and tumor differentiation in cancer.^\[[@R27],[@R32],[@R35]\]^ Three studies with 83 SNSCC patients evaluated the correlation between p53 expression and histological type in cancer.^\[[@R31],[@R32],[@R35]\]^ Their baseline characteristics are summarized in Table [1](#T1){ref-type="table"}.
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The baseline characteristics of eligible studies.
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3.2. Correlation of p53 expression in cancer versus control groups
------------------------------------------------------------------

In this study, the random-effects model was applied to make the results more reliable. The pooled OR indicated that the level of p53 expression in SNSCC tissues was notably higher than in benign sinonasal papillomas and normal sinonasal mucosa by using IHC (OR = 26.93, 95% CI = 11.41--63.55, *P* \< 0.001; OR = 39.79, 95% CI = 10.60--149.36, *P* \< 0.001; respectively) (Fig. [2](#F2){ref-type="fig"}). This analysis suggested that p53 overexpression was significantly correlated with an increased risk of SCC of the sinonasal tract.

![Forest plot of p53 expression in SNSCC versus benign sinonasal papillomas and normal sinonasal mucosa, SNSCC versus benign sinonasal papillomas: OR = 26.93, 95% CI = 11.41--63.55, *P* \< 0.001; SNSCC versus normal sinonasal mucosa: OR = 39.79, 95% CI = 10.60--149.36, *P* \< 0.001.](medi-96-e6424-g003){#F2}

3.3. Subgroup analyses of ethnicity in cancer versus control groups
-------------------------------------------------------------------

According to ethnic population, subgroup analyses were applied to explore the difference of correlation in different subgroups. When SNSCC was compared to benign sinonasal papillomas, subgroup ethnicity analyses indicated that there was significant correlation between p53 expression and SNSCC in Asians, Caucasians, and mixed population (OR = 36.20, 95% CI = 11.10--118.06, *P* \< 0.001; OR = 35.17, 95% CI = 11.53--107.29, *P* \< 0.001; OR = 3.25, 95% CI = 1.26--8.41, *P* = 0.015; respectively) (Fig. [3](#F3){ref-type="fig"}).

![Forest plot of p53 expression based on subgroup ethnicity analyses in SNSCC versus benign sinonasal papillomas, Asians: OR = 36.20, 95% CI = 11.10--118.06, *P* \< 0.001; Caucasians: OR = 35.17, 95% CI = 11.53--107.29, *P* \< 0.001; mixed population: OR = 3.25, 95% CI = 1.26--8.41, *P* = 0.015.](medi-96-e6424-g004){#F3}

When SNSCC was compared to normal sinonasal mucosa, subgroup ethnicity analyses demonstrated that significant association was observed between p53 expression and SNSCC in Asians and Caucasians (OR = 37.33, 95% CI = 7.96--174.99, *P* \< 0.001; OR = 47.42, 95% CI = 3.67--613.03, *P* = 0.003; respectively) (Fig. [4](#F4){ref-type="fig"}). Especially, the result of mixed population subgroup should be carefully considered as only one study was analyzed in our study.

![Forest plot of p53 expression based on subgroup ethnicity analyses in SNSCC versus normal sinonasal mucosa, Asians: OR = 37.33, 95% CI = 7.96--174.99, *P* \< 0.001; Caucasians: OR = 47.42, 95% CI = 3.67--613.03, *P* = 0.003.](medi-96-e6424-g005){#F4}

3.4. A sensitivity analysis of p53 expression in cancer versus benign sinonasal papillomas
------------------------------------------------------------------------------------------

A substantial heterogeneity was measured in cancer versus benign sinonasal papillomas (*P* = 0.016). Thus, we conducted a sensitivity analysis by omitting an individual study to assess the stability of the pooled result and change of heterogeneity. Therefore, we deleted this study by Lin et al,^\[[@R24]\]^ recalculated the pooled OR from remaining 15 studies and shown in Fig. [5](#F5){ref-type="fig"}. Our result revealed that the overall OR of p53 expression was not notably changed (OR = 30.00, 95% CI = 14.65--61.44, *P* \< 0.001). *P*-value of the heterogeneity dramatically increased to 0.359, indicating that the heterogeneity was very low. Our analysis suggested that the result of p53 expression was stable in the comparison of SNSCC and benign sinonasal papillomas.

![Forest plot of p53 expression based on a sensitivity analysis in SNSCC versus benign sinonasal papillomas, OR = 30.00, 95% CI = 14.65--61.44, *P* \< 0.001, with the absence of heterogeneity (*P* = 0.359).](medi-96-e6424-g006){#F5}

3.5. Correlation of p53 expression with clinicopathological characteristics in cancer
-------------------------------------------------------------------------------------

The association of p53 expression with clinicopathological features was also further evaluated in this study. The overall OR including 3 studies with 47 moderately or poorly differentiated SCC patients and 25 well-differentiated SCC patients showed that p53 expression was significantly higher in moderately or poorly differentiated SNSCC than in well-differentiated SNSCC (OR = 3.51, 95% CI = 1.21--10.18, *P* = 0.021) (Fig. [6](#F6){ref-type="fig"}A). The overall OR including 3 studies with 49 keratinizing squamous cell carcinoma (KSCC) and 34 nonkeratinizing squamous cell carcinoma (NKSCC) showed that p53 expression was not correlated with histological type (OR = 0.54, 95% CI = 0.21--1.37, *P* = 0.194) (Fig. [6](#F6){ref-type="fig"}B). However, the analyses of p53 expression with clinicopathological features were cautious due to smaller sample sizes.

![Forest plot of p53 expression with clinicopathological features, (A) (tumor differentiation: OR = 3.51, 95% CI = 1.21--10.18, *P* = 0.021); (B) (histological subtype: OR = 0.54, 95% CI = 0.21--1.37, *P* = 0.194).](medi-96-e6424-g007){#F6}

3.6. Publication bias
---------------------

Egger test was performed to identify the possible publication bias. There was a substantial evidence of publication bias in SNSCC versus benign sinonasal papillomas (*P* \< 0.001) (Fig. [7](#F7){ref-type="fig"}A), however, no evidence of significant publication bias was found in SNSCC versus normal sinonasal mucosa (*P* = 0.260) (Fig. [7](#F7){ref-type="fig"}B).

![Forest plot of publication bias based on Egger test in SNSCC versus benign sinonasal papillomas and normal sinonasal mucosa, (A) (SNSCC vs benign sinonasal papillomas: *P* \< 0.001), (B) (SNSCC vs normal sinonasal mucosa: *P* = 0.260).](medi-96-e6424-g008){#F7}

4. Discussion
=============

In human malignant tumors, p53 is the most frequently inactivated tumor suppressor gene.^\[[@R17]\]^ Reduction of expression of wild-type p53 can contribute to abnormal cell proliferation and carcinogenesis, while mutant p53 may facilitate cell migration, cell invasion, and cell metastasis.^\[[@R39]\]^ Some studies show that positive/high p53 expression is correlated with the development and progression of tumor in several human cancers.^\[[@R40],[@R41]\]^ However, the results of p53 expression are still inconsistent and controversial in SNSCC. Different expression levels of the p53 gene were reported in different studies, ranging from 33.3%^\[[@R26]\]^ to 100%^\[[@R23]\]^ in SNSCC. In addition, the expression levels of the p53 gene were different benign sinonasal papillomas, with a range from 0%^\[[@R27]\]^ to 58.3%.^\[[@R23]\]^ Therefore, the present study was first determined whether p53 expression was significantly associated with the risk of SNSCC. Furthermore, we also determined whether p53 expression was correlated with clinicopathological characteristics in SNSCC.

Sinonasal papillomas are benign epithelial neoplasms of the paranasal sinuses, generally with local invasiveness, higher recurrence rate, could be transformed to SNSCC.^\[[@R28],[@R42]\]^ The p53 expression by using immunohistochemistry (IHC) was shown to be significantly higher in SNSCC than in benign sinonasal papillomas and normal sinonasal mucosa, which suggested that p53 overexpression plays an important role in the tumorigenesis of SNSCC. However, when cancer was compared to benign sinonasal papillomas, a significantly heterogeneity was found (*P* = 0.016). Thus, a sensitivity analysis was performed to evaluate the stability of the result and change of heterogeneity by deleting this study by Lin et al.^\[[@R24]\]^ The result showed that the pooled OR of p53 expression was not significantly changed. Additionally, a *P*-value of the heterogeneity was very low (*P* = 0.359), indicating that the stability of our analysis.

Next, when cancer was compared to benign sinonasal papillomas or normal sinonasal mucosa, subgroup analyses of ethnicity were conducted to find the significant difference of association in different subgroups. Our findings revealed that p53 expression was significantly correlated with SNSCC in Asian and Caucasian populations. Meanwhile, the pooled OR of Asian population and Caucasian population subgroups was not significantly different in our study. The results suggested that Asian and Caucasian populations were susceptible to the p53 gene. However, the results should be careful with caution as only small subjects were analyzed in the comparison of cancer and normal sinonasal mucosa, especially in subgroup ethnicity analyses.

We further determined whether p53 expression was correlated with clinicopathological parameters in SNSCC. We found that the expression of p53 was not correlated with histological subtype of SNSCC. However, the expression of p53 was correlated with tumor differentiation, and higher in moderately or poorly differentiated SNSCC than in well-differentiated SNSCC (OR = 3.51, *P* = 0.021), which suggested that p53 overexpression may play a key role in the progression of SNSCC. While the analyses of p53 expression with clinicopathological parameters should be carefully considered because of small sample size were included in our study. Additional studies with larger sample size are very necessary to further validate the results of p53 expression with more clinicopathological parameters, such as tumor stage in the future.

There were several limitations in the present meta-analysis. First, although we try to search the above databases as completely as possible, a publication bias was detected in SNSCC versus benign sinonasal papillomas. Articles published in Chinese and other language were excluded due to the fact that they were easily unreadable content, in addition, unpublished papers or conference abstracts were excluded based on insufficient information. Second, Asian and Caucasian populations were included in this study, but other ethnicities, such as Africans, were lacking. Third, because of the limitation of studies with sufficient data, we did not analyze the correlation of p53 expression status with other clinicopathological features, such as tumor stage and gender status etc. Thus, large-scale studies with larger subjects should be essential to confirm the results in the future.

In conclusion, our findings suggested that p53 overexpression was significantly associated with an increased risk of SNSCC, in addition, p53 overexpression was significantly higher in moderately or poorly differentiated SNSCC than in well-differentiated SNSCC. The overexpression of p53 was not correlated with histological subtype. Further large-scale researches are needed to provide more insight into the clinical effects of p53 overexpression in SNSCC patients.

We thank all authors for providing the eligible papers published in the public domain.

Abbreviations: 95% CI = 95% confidence interval, IHC = immunohistochemistry, KSCC = keratinizing squamous cell carcinoma, NKSCC = nonkeratinizing squamous cell carcinoma, OR = odds ratio, SNSCC = sinonasal squamous cell carcinoma.
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